10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Somatic inactivation of Pkd2 results in polycystic kidney disease.

      Cell
      Alleles, Animals, Clone Cells, Crosses, Genetic, DNA, analysis, Exons, genetics, Genotype, Kidney, chemistry, pathology, Liver, Loss of Heterozygosity, Membrane Proteins, physiology, Mice, Mice, Knockout, Mutation, Polycystic Kidney, Autosomal Dominant, RNA, Messenger, Recombination, Genetic, Restriction Mapping, Stem Cells, TRPP Cation Channels

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Germline mutations in PKD2 cause autosomal dominant polycystic kidney disease. We have introduced a mutant exon 1 in tandem with the wild-type exon 1 at the mouse Pkd2 locus. This is an unstable allele that undergoes somatic inactivation by intragenic homologous recombination to produce a true null allele. Mice heterozygous and homozygous for this mutation, as well as Pkd+/- mice, develop polycystic kidney and liver lesions that are indistinguishable from the human phenotype. In all cases, renal cysts arise from renal tubular cells that lose the capacity to produce Pkd2 protein. Somatic loss of Pkd2 expression is both necessary and sufficient for renal cyst formation in ADPKD, suggesting that PKD2 occurs by a cellular recessive mechanism.

          Related collections

          Author and article information

          Comments

          Comment on this article